Proteinase 3 phosphonic inhibitors.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 12 02 2019
accepted: 07 03 2019
pubmed: 17 3 2019
medline: 31 12 2019
entrez: 17 3 2019
Statut: ppublish

Résumé

Neutrophils are one of the most important military services of the armed forces of the immune system, a crucial line of defense against bacterial or fungal onslaughts. One of their mechanisms of action relies on the production of serine proteases. One of these enzymes is proteinase 3 (PR3), which is engaged in the processing of pro-inflammatory cytokines, receptors, heat shock proteins and in the generation of antibacterial peptides. Despite its protective function, uncontrolled activity of PR3 has been associated with the progression of inflammation and tissue injury. Although PR3 was characterized at the beginning of 90's of the last century for the first time, the research on the development of its inhibitors is barely noticeable. Here we present the recent findings on the design, synthesis and the activity of phosphonic PR3 inhibitors together with the historical perspective.

Identifiants

pubmed: 30876969
pii: S0300-9084(19)30072-0
doi: 10.1016/j.biochi.2019.03.005
pii:
doi:

Substances chimiques

Organophosphonates 0
Serine Proteinase Inhibitors 0
Myeloblastin EC 3.4.21.76

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-149

Informations de copyright

Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Auteurs

Renata Grzywa (R)

Wroclaw University of Science and Technology, Faculty of Chemistry, Division of Medicinal Chemistry and Microbiology, Wybrzeże Wyspiańskiego 27, 50-370, Wrocław, Poland. Electronic address: renata.grzywa@pwr.edu.pl.

Adam Lesner (A)

University of Gdansk, Faculty of Chemistry, Wita Stwosza 63, 80-308, Gdansk, Poland.

Brice Korkmaz (B)

INSERM U-1100, "Centre d'Etude des Pathologies Respiratoires" and Université François Rabelais, 37032, Tours, France.

Marcin Sieńczyk (M)

Wroclaw University of Science and Technology, Faculty of Chemistry, Division of Medicinal Chemistry and Microbiology, Wybrzeże Wyspiańskiego 27, 50-370, Wrocław, Poland. Electronic address: marcin.sienczyk@pwr.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH